Related by context. All words. (Click for frequent words.) 73 therapeutic monoclonal antibodies 72 commercialize Aganocides 72 commercializing anti infective 72 Provectus Pharmaceuticals specializes 71 Dacetuzumab 71 acne impetigo 70 RECOTHROM ® 69 NovaBay Aganocide compounds 69 adrenergic regulation 69 kidney urologic 69 commercialize deforolimus 68 dermatology therapies 68 targeted anticancer biopharmaceuticals 68 novel antiviral therapeutics 68 oncolytic virus therapies 68 monoclonal antibody therapeutics 68 POTELLIGENT ® 68 CCR9 antagonist 68 TRACON Pharmaceuticals 68 proprietary PEGylation 68 romazarit 68 P#X# antagonist 68 HuMax TAC 67 gastro intestinal inflammation 67 Nasdaq HALO biopharmaceutical 67 novel RNAi therapeutics 67 oral prodrug 67 NuMimetic TM 67 Ibis T# TM 67 Nanobody 67 cancer immunotherapies 67 commercialize becocalcidiol patented 67 Disease IBD 67 Nutra Pharma wholly owned 67 ADCC enhanced 67 candidates Azedra TM 67 antisense drugs 67 therapeutic monoclonal antibody 67 NYSE Amex AEN 67 anticancer compounds 67 products Oncaspar 67 AB OMXS BINV 67 personalized cellular immunotherapy 67 commercialize Aganocide compounds 67 immunotherapeutics 67 Onalta 67 peptide peptide mimetic 67 Liprotamase 66 UltiMAb 66 XOMA discovers develops 66 Endotis 66 DPX Survivac 66 Lipocine 66 Nanobody R 66 ionotropic glutamate receptor antagonists 66 mertansine 66 novel immunotherapies 66 FOLOTYN ® 66 cosmetic cosmeceutical products 66 XL# anticancer compounds 66 Pancreate 66 tiapamil 66 Avila Therapeutics 66 Epiphany Biosciences 66 Kosan dependence 66 THR beta agonist 66 CD# monoclonal antibody 66 humanized monoclonal antibodies 66 Lixivaptan 66 Thrombin topical Recombinant 66 TRANSDUR ® 66 BCR ABL inhibitors 66 proprietary intranasal insulin 66 Aviptadil 66 topical anti infective 66 psoriasis rheumatoid arthritis 66 Brussels THR 66 intranasal insulin product 66 investigational humanized monoclonal antibody 66 R sorafenib tablets 66 rxRNA 66 novel therapeutic antibodies 66 molecular imaging radiopharmaceutical 66 4SC AG ISIN DE# 66 commercialize apixaban 66 anticancer therapeutics 66 selective immunoproteasome inhibitor 66 RNA interference RNAi therapeutics 66 TRANSDUR ™ 66 Vaccinex 66 mucosal vaccines 66 aerosolized AAT 66 Zalypsis 65 Scancell 65 Nanobody ® 65 small molecule thrombopoietin 65 human antibody therapeutics 65 monoclonal antibody MAb 65 commercialize SGN 65 Vitamin D analogue 65 PORxin TM platforms 65 signal averaging electrocardiography 65 commercializing therapeutic 65 anti infective treatments 65 multi kinase inhibitor 65 Nasdaq OMER biopharmaceutical 65 New Chemical Entities 65 GVAX ® 65 IAP inhibitors 65 MorphoSys Galapagos 65 dihydrochloride Tablets 65 GlycArt 65 Spectrum Pharmaceuticals acquires 65 Epitomics 65 immunological diseases 65 HuCAL GOLD ® 65 www.ucb group.com 65 Teikoku Pharma USA 65 CD# CEA 65 Chemetics R 65 Crofelemer budesonide foam 65 CYT# potent vascular disrupting 65 liposomal delivery 65 JAK2 inhibitor 65 product platforms AZX# 65 Selective Electrochemical Tumor Ablation 65 targeted immunotherapies 65 trademarks Vitrasert R 65 treat male hypogonadism 65 novel anti infective 65 targeted radiotherapeutic 65 immatics 65 commercialize OncoGenex lead 65 commercialize XP# 65 infectious diseases autoimmune diseases 65 oral Janus kinase 65 immuno inflammatory diseases 65 candidates Azedra 65 HuCAL PLATINUM ® CysDisplay 65 ImmunoGen TAP technology 65 StromaCel Inc. 65 Currently RegeneRx 65 immunotherapeutic approaches 65 LymphoStat B belimumab 65 include PLX IBD 65 CRMD pharmaceutical 65 molecular chaperone regulation 65 Archemix Corp. 64 BHT DNA 64 commercializing aptamer therapeutics 64 HepDirect R 64 nitric oxide donating 64 Inc. AMEX YMI 64 Friedreich Ataxia FRDA 64 predictive biomarkers 64 Viprovex TM 64 topically delivered 64 rusalatide acetate 64 ocular formulation 64 ELADUR TM 64 ospemifene 64 oncolytic viruses 64 Initiates Enrollment 64 Dyax phage display 64 novel peptides 64 MyVax R 64 Locked Nucleic Acid 64 Oracea TM 64 VitiGam 64 commercializing novel biotherapeutics 64 Solazed TM 64 Biopharma OTCBB VODG 64 ELADUR ™ 64 Onalta TM 64 candidate custirsen 64 CDP# 64 vitreoretinal disorders 64 Aganocide ® 64 Zemiva TM 64 Zenapax 64 skeletal muscle weakness 64 NYSE Amex PBTH 64 RECOTHROM R 64 PI3K/Akt pathway inhibitor 64 external counterpulsation systems 64 MAbs targeting 64 molecular therapeutics immunotherapies 64 Crop BioScience 64 label Lipofen R 64 MEK inhibitors 64 CysDisplay R 64 TLR9 agonists 64 AzaSite Xtra 64 organ transplant rejection 64 Intravenous Human 64 novel peptide 64 calcium phosphate nanotechnology CaP 64 HepeX B TM 64 LentiVector technology 64 Personalized Immunotherapy 64 superior biotherapeutics 64 RONDEL ™ 64 Alvine Pharmaceuticals 64 adenosine A2A 64 Adnectin 64 treat gastrointestinal disorders 64 commercialize Hematide 64 Fludara ® 64 Unit Dose Budesonide 64 Adenosine Therapeutics 64 MKC# MKC# PP 64 OTCBB INSV 64 Campath ® 64 humanized anti 64 small molecule agonists 64 MTP inhibitor 64 antiangiogenesis therapies 64 KL4 Surfactant 64 microRNA therapeutics 64 acetonide FA 64 polysaccharide polymer 64 Idera Pharmaceuticals 64 methylnaltrexone bromide 64 anti aging glycopeptides 64 Galenea 64 botanical therapeutics 64 subsidiaries visit http:/www.apricusbio.com 64 anticoagulant reversing agent 64 Azedra 64 taxane derivative 64 IMiDs ® 64 TRIOLEX HE# APOPTONE HE# 64 muscarinic receptor agonists 64 NTDDS 64 Pharma Merck Serono 64 isoform selective 64 selective angiogenic kinase inhibitor 64 OTCBB NPHC biotechnology 64 purinergic receptors P#X# 64 IgG1 monoclonal antibody 64 TM Aganocide 64 aptamer therapeutics 64 RELISTOR ® 64 rheumatoid arthritis thrombocytopenia 64 treat refractory angina 64 either acutely decompensated 64 ophthalmic diseases 64 POTELLIGENT R Technology 64 oral ghrelin agonist 64 MDRNA proprietary 64 Nicotine Conjugate Vaccine 64 sulfonylhydrazine class 64 novel immunomodulatory 64 constipation OIC 64 Xcytrin R 64 commercializes VIVITROL ® 63 Prodarsan R 63 JAK inhibitor 63 Taiho Pharmaceutical 63 Epothilones 63 Droxidopa Chelsea 63 OGeS 63 Galderma SA 63 Endotoxin Activity Assay 63 Initiates Clinical Trial 63 recombinant antibodies 63 antisense inhibitors 63 oral proteasome inhibitor 63 Initiates Phase II 63 HuCNS SC ® 63 Aganocide TM 63 Nasdaq LXRX biopharmaceutical 63 biosurgical 63 GlaxoSmithKline MedImmune 63 rHuPH# recombinant human 63 Through Glycoscience R 63 NASDAQ BTRX pharmaceutical 63 Teplizumab 63 HepeX B 63 Silodosin 63 Cephalon GlaxoSmithKline 63 sorafenib tablets 63 VentiRx 63 Factor VIIa 63 commercialize microRNA therapeutics 63 IMiDs R 63 pharmacological chaperone 63 Fresenius Biotech 63 Innovive Pharmaceuticals 63 Zenyaku Kogyo 63 Etubics 63 Neutrolin ® 63 NS5b 63 vaccines oncolytic virus 63 autoimmune uveitis 63 Panzem R 63 developing Bicifadine serotonin 63 HCV protease inhibitors 63 Augment TM 63 hereditary emphysema 63 Roche SWX ROG 63 OTCBB PYTO 63 Tibotec Therapeutics division 63 Roche SIX RO 63 ALN PCS 63 enhanced skin permeation 63 Cellgate Inc. 63 Adrenomyeloneuropathy AMN HIV 63 Promedior 63 Smac mimetics 63 Alligator Bioscience AB 63 SAR# [002] 63 include Altastaph TM 63 Inc. dba Vitro 63 KAI Pharmaceuticals Inc. 63 antibody fragment therapeutics 63 investigational pharmacologically unique 63 Archexin 63 Avian Transgenic Technology 63 catalytic antioxidant compounds 63 anti CD3 monoclonal 63 APC Targeting Technology 63 R#/MEM 63 telomerase therapeutic 63 theranostic 63 immunologic diseases 63 Kosan epothilone program 63 HELSINN 63 TNF Tumor Necrosis Factor 63 Pentad TM 63 Tumour Vascular Disrupting Agent 63 FoldRx 63 oral Factor Xa 63 LHRH antagonists 63 lead molecular radiotherapeutic 63 introduced NEUGENE 63 Myocet 63 PDE# inhibitors 63 commercializing Loramyc ® 63 Xanthus Pharmaceuticals Inc. 63 HuCAL GOLD R 63 SIX RO ROG 63 anticancer therapies 63 Modrenal R 63 ReCyte 63 Tibotec BVBA 63 faropenem medoxomil 63 MCSP respectively 63 Nanobodies ® 63 Prochymal TM 63 Kuvan R 63 delivers sumatriptan 63 ATL# [002] 63 AKIP ™ 63 YM AIM YMBA 63 diabetes irritable bowel 63 INxin TM 63 mild vasodilator 63 Locked Nucleic Acid LNA 63 vaccine GRNVAC1 63 Myolimus 63 proprietary dermal 63 orthobiologic 63 Angiocept 63 coronary stent merged 63 SARMs 63 candidate deforolimus 63 Cerimon 63 nicotinic alpha 7 63 Syndax Pharmaceuticals Inc. 63 vaginal candidiasis 63 hypoxia selective 63 Potelligent Technology 63 SPL# Gel vaginal microbicide 63 Surfaxin LS 63 GI motility disorders 63 Bioral 63 UCB www.ucb group.com 63 IMA# 63 bucindolol hydrochloride 63 dSLIM 63 small molecule glucokinase 63 Nasdaq MITI biopharmaceutical 63 Stapled Peptide 63 Serostim ® 63 Therapeutic Competitors companiesandmarkets.com adEgemonye 63 specific lectin receptors 63 Luveris R Ovidrel R 63 Neurimmune 63 AAG geldanamycin analog 63 synthetic retinoid 63 investigational monoclonal antibody 63 Initiates Dosing 63 proprietary BiTE ® 63 relapsed leukemia 63 oral taxane 63 TOCOSOL Camptothecin 63 fusion enhancers 63 Daclizumab 63 LymphoStat B TM 62 proprietary biomaterials 62 investigational compounds 62 HYVISC ® treatment 62 Septin9 biomarker 62 Applied NeuroSolutions 62 IV Busulfex 62 Therapeutic Competitors Companies 62 Nycomed GmbH 62 LEVADEX ™ 62 HuCAL antibody 62 oncology therapeutics 62 preclinical compounds 62 selective androgen receptor modulators 62 Novosom 62 epothilones 62 Creabilis Therapeutics 62 photodisinfection 62 Combivir Kivexa 62 Naglazyme R 62 rxRNA TM compounds 62 MSCRAMM ® 62 POTELLIGENT R 62 Arno Therapeutics 62 Inc. www.micromet inc.com 62 Civacir 62 Igeneon 62 Paramount BioSciences 62 developing Zerenex TM 62 developing Surfactant Replacement 62 Nexavar ® 62 IMiDs 62 Proxinium TM 62 Affibody ® molecules 62 PARI Pharma 62 LEVADEX TM 62 muco adhesive technology 62 candidate epratuzumab 62 Aradigm Logo 62 KL4 surfactant 62 humanized monoclonal antibody 62 YONDELIS R 62 identify protein biomarkers 62 ProNAi 62 CyDex Pharmaceuticals Inc. 62 markets HP Acthar 62 CD# antibody [001] 62 pipeline ImmunoGen collaborators 62 beta islets 62 UltiMAb TM 62 manufacturing interventional vascular 62 PEGylation technology 62 Cerashield ™ 62 Curaxin 62 Alder Biopharmaceuticals Inc. 62 Tikvah Therapeutics 62 including thyroiditis RA 62 Merrimack Pharmaceuticals 62 Bucindolol 62 NASDAQ SNTA biopharmaceutical 62 Evoltra ® 62 Annamycin 62 peptidic compound 62 polyclonal antibodies 62 Onconase 62 HuCAL PLATINUM R 62 small molecule modulators 62 Symphogen 62 Ercole Biotech 62 PROfusion 62 JAK inhibitors 62 attach auristatin 62 Anticalins R 62 StaphVAX R 62 Ceflatonin R 62 ENMD # 62 MKC# MT 62 platforms GVAX 62 pralatrexate injection folate analogue 62 novel BiTE antibodies 62 MERREM 62 SECTA therapy 62 ArQule Kinase Inhibitor Platform 62 inflammatory autoimmune diseases 62 Potelligent TM Technology 62 theranostics 62 ThermoDox R 62 manufactures minimally invasive 62 refractory gout 62 Solazed ™ 62 virosome 62 MyVax ® 62 deforolimus 62 INS# [001] 62 targets Galectin receptors 62 huC# DM4 62 targeting Inflammatory Bowel 62 BioSpecifics Technologies Corp. 62 Adamis Viral Therapies 62 ACTCellerate 62 delta opioid receptor 62 Ampakine compounds 62 drug pipeline TAFA# 62 rxRNA ™ compounds 62 SEQureDx ™ 62 BioWa 62 antisense drug 62 bio therapeutics 62 Receptos 62 BXT # 62 renin inhibition promising 62 compound KOS 62 induced macular edema 62 delay bone metastases 62 About Positron Positron 62 Potelligent 62 HuCAL antibodies 62 Xytis 62 factor TNF receptor 62 angioedema indications 62 Dicer Substrate Technology 62 OXIGON TM 62 Nasdaq IMGN biotechnology 62 carcinoid syndrome diabetes 62 Afferent Pharmaceuticals 62 Transdel TM platform 62 Prism Pharmaceuticals 62 ZFP Therapeutics 62 investigational pan BCR 62 ATryn GTC 62 commercialize Dimebon 62 humanized antibodies 62 polyneuropathy HIV DSP 62 infectious diseases autoimmune 62 Initiate Clinical Trial 62 Aurexis R 62 PD2i CA Cardiac Analyzer 62 HCV NS3 protease 62 Iluvien ® 62 AcryMed technologies 62 RNA antagonists 62 Restoraderm R technology 62 Alnylam RNAi 62 human monoclonal antibody 62 Myotech 62 CTAP# Capsules 62 TRAIL receptor antibodies 62 biodefense pathogens 62 Vegenics 62 ATryn ® GTC recombinant 62 Insegia 62 personalized immunotherapy 62 Oasmia 62 Exelixis compounds 62 muscarinic receptor agonist 62 Reports Preclinical Data 62 Fovea Pharmaceuticals 62 Alseres Cethrin 62 OncoVex 62 #/#/# Cytokinetics Incorporated 62 proteasome inhibitor 62 mGluR5 PAM 62 custom oligonucleotides 62 Zolpimist ™ 62 siRNA compounds 62 Quark Biotech 62 Generx TM 62 GTC recombinant human 62 NOTE POSIDUR ™ 62 NASH Huntington 62 ophthalmology oncology 62 NP2 Enkephalin 62 monoclonal antibodies MAbs 62 XSSE OXGN 62 IMPACS R 62 Medarex UltiMAb R 62 serious systemic Staphylococcal 62 reslizumab 62 XmAb ™ 62 Nasdaq IMGN biopharmaceutical 62 OMP #M# 62 Staphylococcus aureus Immune Globulin 62 Aganocide compounds 62 SinuNase ™ 62 XOMA develops 62 Atripla combines 62 Rhucin ® recombinant 62 OTCQB CTIX 62 Fleximer 62 tranilast 62 acyclovir Lauriad R 62 Ofatumumab 62 recombinant biopharmaceutical 62 equine osteoarthritis marketed 62 rheumatoid arthritis multiple sclerosis 62 OTCBB IMNR 62 recombinant polyclonal antibodies 62 mocetinostat MGCD# 62 Amira Pharmaceuticals 62 Sphingomab TM 62 compound perifosine 62 non personalized allogeneic 62 Micromet proprietary BiTE 61 TLR9 agonist 61 Circ Pharma 61 Chrysalin 61 peptibody 61 Quark Biotech Inc. 61 commercialize elagolix 61 Ikaria Holdings Inc. 61 Albugon 61 PAION AG ISIN 61 therapy Atrigel R 61 Adagen ® 61 drug ISA# 61 antisense therapeutics 61 BioMAP ® Systems 61 humanized monoclonal 61 ELND-#/AZD-# 61 lipid nanoparticle 61 polymerase inhibitors 61 Ceragenix 61 dermatological diseases 61 Oxford Genome Sciences 61 Glassia 61 product Fentanyl TAIFUN 61 Idun Pharmaceuticals 61 OncoVEX 61 brand ciclesonide HFA 61 BioVant 61 acquires researches develops 61 OHR/AVR# 61 DNA methylation biomarkers 61 MultiCell Technologies 61 GM DUSA dermatology 61 antibacterial therapeutics 61 siRNA therapeutics 61 Piperacillin 61 Nereus Pharmaceuticals 61 PregLem 61 DNAi 61 Tarmogen 61 FUSILEV ® 61 Veronate R 61 Inc Therapeutic Competitors 61 EndoTAG TM 61 atopic dermatitis neonatal 61 Anidulafungin 61 PsychoGenics 61 inflammatory autoimmune 61 Aflibercept 61 Hemopurifier ® 61 Anticalin R 61 sells cGMP paclitaxel 61 Shigamabs ® 61 Ostarine ™ 61 hyperimmune products 61 Homspera TM 61 HuLuc# 61 encapsulates siRNAs 61 IAP inhibitor 61 agonistic human 61 dutogliptin 61 oral probiotic 61 serine protease inhibitor CU# 61 biased ligand 61 CK # skeletal muscle 61 antibody therapeutics 61 commercialize microRNA 61 Ribavirin causes 61 HepaGam B TM 61 using VIAdel TM 61 promotes MERREM ® 61 HQK 61 DURECT proprietary 61 recombinant subunit vaccine 61 Euroscreen 61 IV meropenem 61 biologic therapeutics 61 Affilin ® 61 Crucell PER.C6 ® 61 transfection reagents 61 PRT# 61 erlotinib Tarceva R 61 tubulin inhibitor 61 ProtAffin 61 vii Cubist ability 61 Bioral Amphotericin B 61 GenWay Biotech 61 vapreotide acetate 61 syndrome overactive bladder 61 RTP #i 61 gastrointestinal mucositis 61 Aegera 61 targeted anticancer therapies 61 candidate CRLX# 61 Nasdaq XTLB 61 NPC 1C 61 antibody MAb 61 Affimed 61 BioInvent 61 Survivin antagonist 61 allogeneic cell 61 Cylene 61 Gemin X 61 COMPLEGENT TM Technologies 61 patented Bioral 61 Ocrelizumab 61 neuropathic pain metabolic diseases 61 mGluR4 PAM 61 RNAi therapeutic targeting 61 Inc. Nasdaq INFI 61 Microbix specializes 61 ALTROPANE R 61 recurrent metastatic ovarian cancer 61 Adagen 61 Ube Industries Ltd. 61 programs visit http:/www.bionovo.com 61 small molecule PEGylation 61 AEG# 61 AtuRNAi 61 anti amnesic 61 resorbable biomaterials 61 virus HCV protease inhibitor 61 CTLA4 Ig 61 volociximab 61 phenylketonuria PKU developed 61 Profectus BioSciences 61 pharmacological chaperones 61 endothelin antagonist 61 Nasdaq CRXL 61 Nautilus Biotech 61 Completes Patient Enrollment 61 DepoDur 61 bendamustine HCl 61 topically applied SEPA 61 LEAD Therapeutics 61 immunomodulators 61 sodium glucose transporter 61 humanized therapeutic 61 therapeutic antibodies 61 commercialize dutogliptin 61 diarrhea predominant irritable 61 SGLT Inhibitors 61 Syntonix 61 DBV Technologies 61 acting fibrinolytic 61 AngioChem 61 Gemin X Biotechnologies 61 expanded autologous cellular 61 Oral Suspension USP 61 injectable collagenase 61 Eraxis 61 YONDELIS 61 Vaxfectin 61 Virosome Biologicals 61 GlycoPEGylated hemostasis compounds 61 Juvaris BioTherapeutics 61 NNR Therapeutics 61 PRNewswire FirstCall YM BioSciences 61 BCG refractory carcinoma 61 Ception Therapeutics 61 Cardium Therapeutics TM 61 Inc. AMEX LIV 61 PNP inhibitor 61 addressing idiopathic pulmonary 61 AcryMed Incorporated 61 CORT # 61 hypereosinophilic syndrome 61 MOVIPREP R 61 Fc fusion protein 61 refractory chronic lymphocytic 61 commercialize MDV# 61 RNA antagonist 61 developing ACAPODENE 61 Darapladib 61 DispersinB ® 61 OPi 61 delivery polymer matrix 61 herpes simplex viruses 61 Targeted Chemotherapy 61 Pharmos pipeline 61 AMPK activators 61 commercializing oxidized glutathione 61 proprietary polysaccharide 61 flavors flavor enhancers 61 Systemic lupus erythematosus SLE 61 immunoregulation 61 selective orally bioavailable 61 GTC NASDAQ GTCB 61 metabolically inert oral antifolate 61 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 61 Restoraderm 61 Meda STO MEDAA 61 GSK Rare Diseases 61 neurology immunology 61 antiviral therapeutics 61 histone deacetylase HDAC 61 Tarvacin TM 61 Calixa Therapeutics 61 ZaBeCor 61 teplizumab 61 sapacitabine CYC# 61 allosteric modulation 61 PHX# 61 Idec Roche Takeda 61 Cenomed 61 Fibrosis Foundation Therapeutics 61 cellular immunotherapy 61 JAK1 61 Merck Serono division 61 Ferring Pharmaceuticals privately 61 Injury ALI 61 Genentech Roche 61 Namenda Memantine HCl 61 molecular biomarkers 61 monocytogenes Listeria vaccines 61 pentadentate logo R 61 Chemokine Therapeutics 61 ZARS Pharma 61 Phylomer ® 61 hepatitis B HBV 61 proprietary capillary aerosolization 61 metaglidasen 61 M# rationally 61 oral dihydropyrimidine dehydrogenase DPD 61 HydroFix TM 61 Aganocide R 61 toenail onychomycosis 61 Advancing Drugs 61 Aeolus Pharmaceuticals 61 Initiates Clinical 61 Corp. Nasdaq BSTC 61 PROLOR Biotech Inc. 61 ulimorelin 61 produces potent VLP 61 Kuvan TM sapropterin 61 molecular imaging radiopharmaceuticals 61 oral dual endothelin 61 ImmuneRegen BioSciences Inc. 61 BioFocus DPI Galapagos 61 cytomegalovirus immune globulin 61 IgG1 antibody 61 NeutroPhase TM 61 Opterone R 61 Commercialize Novel 61 Therapies SRT 61 Inc. Tianlong 61 ImaginAb 61 Nasdaq CGEN 61 Nexavar sorafenib tablets 61 prostone 61 ophthalmic therapeutics 61 oral JAK#/JAK# inhibitor 61 LEUKINE 61 Zacharon 61 Cintredekin Besudotox 61 MEK inhibitor 61 oral antiviral 61 Nektar proprietary 61 HepaMate 61 Vitrasert R 61 Sebivo 61 ASONEP TM 61 ProMune 61 Chipscreen 61 neovascular diseases 61 Nasdaq OMER 61 successfully commercialize Iluvien 61 Optiquel ™ 61 ZFN TM 61 siRNA therapeutic 61 pafuramidine maleate 61 JOULFERON 61 MolecularBreeding 61 novel synthetic peptide 61 engineered proteases 61 ZEVALIN ® 61 Pharmion Corporation 61 MP4 molecule 61 DiLA2 61 DELATESTRYL R 61 Amunix 61 Regulus Therapeutics 61 sapropterin dihydrochloride Tablets 61 candidate XP# 61 Captisol ® 61 NitroMist 61 inhibit metastasis 61 Boehringer Ingelheim MedImmune 61 Inc. www.prometic.com 61 platform HDL Mimetic 61 TLR8 61 Sopherion 61 MEDA AB publ 61 Adamis Laboratories 61 Pharsight Corporation 61 Fovea Pharmaceuticals subsidiary 61 PEGylated 61 HGS ETR1 mapatumumab 61 polymer conjugate technology 61 proven DuraSite ® 61 Potelligent TM 61 commercializes VIVITROL R 61 fluorinated carbohydrate mimics 61 Oral NKTR 61 erlotinib Tarceva ® 61 neuropathic pain spasticity 61 lucinactant 61 Esmya 61 Corixa Corporation 61 EyeGate Pharma 61 Icatibant 61 investigational oral anticoagulant 61 BENLYSTA ® 61 Nasdaq SGEN 60 leading oral taxane 60 Nanobodies R 60 Copegus R 60 Nasdaq ARGN leader 60 Peyronie disease Frozen Shoulder 60 Panzem 60 REMOXY R 60 Biodefense Division 60 Curaxin CBLC# 60 Resurgex Plus R 60 XL# XL# 60 therapeutic antibody 60 MediGene focuses 60 immunotherapeutic 60 PEGylated anti 60 Hybridon 60 XmAb ® 60 validating biomarkers 60 DXL TM 60 antibody therapies 60 Safinamide 60 IMiDs ® compound 60 mitoxantrone concentrate 60 myasthenia gravis Huntington 60 monoclonal antibodies 60 Dapagliflozin 60 ABL inhibitor 60 BioSeek 60 specific CCR9 antagonist 60 accumulate preferentially 60 EyeGate 60 CYT# novel 60 AGS PSCA 60 Revimmune 60 GIPET r 60 Fleximer R 60 Isogenica 60 Squalamine 60 topical dermatological products 60 apricitabine ATC 60 ALN VSP 60 oncologic diseases 60 Genentech sanofi aventis 60 antibody fragment 60 ASG 5ME 60 Sphingomab 60 myeloproliferative disorders 60 preclinically 60 SMaRT ™ 60 REGiMMUNE 60 visit www.genmab.com 60 Spiegelmers R 60 Avidex 60 Shigamabs R 60 HCV NS5B polymerase 60 pathophysiological effects 60 Lpathomab 60 Generx ® 60 ImmunoGen Inc. 60 Pemphigus Vulgaris 60 subcutaneous formulation 60 Retacrit 60 ChromoCure develops 60 Merck OSI Pharmaceuticals 60 Alnara Pharmaceuticals 60 Akesis Pharmaceuticals 60 Inotek Pharmaceuticals Corporation 60 Aeolus Pharmaceuticals Announces 60 FoldRx Pharmaceuticals Inc. 60 TSX YM AIM 60 targeting CD# 60 Nasdaq MNKD focused 60 Nasdaq RXII 60 Amgen discovers develops 60 specific ZFP Nucleases 60 URG# 60 Intravenous CP 60 CEDAX ® 60 recombinant therapies 60 PEGylated Fab fragment 60 drug conjugate 60 Valtropin 60 AutoloGel tm System 60 technology visit http:/www.genmab.com